4948711000001105: Fluorouracil 250mg capsules (Cambridge Laboratories) (product)

• SNOMED CT Concept\Pharmaceutical / biologic product\...
• \UK product\Actual medicinal product\Fluorouracil 250mg capsules (Cambridge Laboratories)
• \UK product\Virtual medicinal product\Product containing precisely fluorouracil 250 milligram/1 each conventional release oral capsule\Fluorouracil 250mg capsules (Cambridge Laboratories)
• \UK product\Virtual therapeutic moiety\Fluorouracil\Product containing only fluorouracil in oral dose form (medicinal product form)\Product containing precisely fluorouracil 250 milligram/1 each conventional release oral capsule\Fluorouracil 250mg capsules (Cambridge Laboratories)
• \UK product\Virtual therapeutic moiety\Fluorouracil\Product containing precisely fluorouracil 250 milligram/1 each conventional release oral capsule\Fluorouracil 250mg capsules (Cambridge Laboratories)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing methyltransferase inhibitor\Product containing thymidylate synthase inhibitor\Product containing fluorouracil\Fluorouracil\Product containing only fluorouracil in oral dose form (medicinal product form)\Product containing precisely fluorouracil 250 milligram/1 each conventional release oral capsule\Fluorouracil 250mg capsules (Cambridge Laboratories)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing methyltransferase inhibitor\Product containing thymidylate synthase inhibitor\Product containing fluorouracil\Fluorouracil\Product containing precisely fluorouracil 250 milligram/1 each conventional release oral capsule\Fluorouracil 250mg capsules (Cambridge Laboratories)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing methyltransferase inhibitor\Product containing thymidylate synthase inhibitor\Product containing fluorouracil\Product containing fluorouracil in oral dose form (medicinal product form)\Product containing only fluorouracil in oral dose form (medicinal product form)\Product containing precisely fluorouracil 250 milligram/1 each conventional release oral capsule\Fluorouracil 250mg capsules (Cambridge Laboratories)
• \Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing antimetabolite\Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product)\Product containing fluorouracil\Fluorouracil\Product containing only fluorouracil in oral dose form (medicinal product form)\Product containing precisely fluorouracil 250 milligram/1 each conventional release oral capsule\Fluorouracil 250mg capsules (Cambridge Laboratories)
• \Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing antimetabolite\Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product)\Product containing fluorouracil\Fluorouracil\Product containing precisely fluorouracil 250 milligram/1 each conventional release oral capsule\Fluorouracil 250mg capsules (Cambridge Laboratories)
• \Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing antimetabolite\Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product)\Product containing fluorouracil\Product containing fluorouracil in oral dose form (medicinal product form)\Product containing only fluorouracil in oral dose form (medicinal product form)\Product containing precisely fluorouracil 250 milligram/1 each conventional release oral capsule\Fluorouracil 250mg capsules (Cambridge Laboratories)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product)\Product containing fluorouracil\Fluorouracil\Product containing only fluorouracil in oral dose form (medicinal product form)\Product containing precisely fluorouracil 250 milligram/1 each conventional release oral capsule\Fluorouracil 250mg capsules (Cambridge Laboratories)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product)\Product containing fluorouracil\Fluorouracil\Product containing precisely fluorouracil 250 milligram/1 each conventional release oral capsule\Fluorouracil 250mg capsules (Cambridge Laboratories)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product)\Product containing fluorouracil\Product containing fluorouracil in oral dose form (medicinal product form)\Product containing only fluorouracil in oral dose form (medicinal product form)\Product containing precisely fluorouracil 250 milligram/1 each conventional release oral capsule\Fluorouracil 250mg capsules (Cambridge Laboratories)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product)\Product containing fluorouracil\Fluorouracil\Product containing only fluorouracil in oral dose form (medicinal product form)\Product containing precisely fluorouracil 250 milligram/1 each conventional release oral capsule\Fluorouracil 250mg capsules (Cambridge Laboratories)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product)\Product containing fluorouracil\Fluorouracil\Product containing precisely fluorouracil 250 milligram/1 each conventional release oral capsule\Fluorouracil 250mg capsules (Cambridge Laboratories)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product)\Product containing fluorouracil\Product containing fluorouracil in oral dose form (medicinal product form)\Product containing only fluorouracil in oral dose form (medicinal product form)\Product containing precisely fluorouracil 250 milligram/1 each conventional release oral capsule\Fluorouracil 250mg capsules (Cambridge Laboratories)
• \Medicinal product\Product manufactured as oral dose form\Product containing fluorouracil in oral dose form (medicinal product form)\Product containing only fluorouracil in oral dose form (medicinal product form)\Product containing precisely fluorouracil 250 milligram/1 each conventional release oral capsule\Fluorouracil 250mg capsules (Cambridge Laboratories)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
18356701000001116	Fluorouracil 250mg capsules (Cambridge Laboratories) (product)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
41506901000001116	Fluorouracil 250mg capsules (Cambridge Laboratories Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module

Expanded Value Set

This concept is not in any reference sets

Back to Start